Ocular delivery of cyclosporin A I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion

S.T.P. Pharma Sciences

Volumn 11, Issue 6, 2001, Pages 421-426

  Tamilvanan, S ^a   Khoury, K ^a   Gilhar, D ^a   Benita, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cyclosporin A; pH; Stability; Submicron emulsion; Zeta potential

Indexed keywords

CYCLOSPORIN A; FATTY ACID; PHOSPHOLIPID;

ARTICLE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; EMULSION; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRECIPITATION; SOLUBILIZATION; ZETA POTENTIAL;

EID: 0035659274     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporin A in rats
2. In vitro study of cyclosporin absorption: Vehicles and intestinal immaturity
3. Bioavailability of cyclosporin in rats after intragastric administration: A comparative study on the L2-phase and two other lipid-based vehicles
4. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats
5. Alternative cyclosporin metabolic pathways and toxicity
6. Cyclosporin absorption is impaired by the fat substitutes, sucrose polyester and tricarballylate triester, in the rat
7. Enhanced intestinal absorption of cyclosporin in rats through the reduction of emulsion droplet size
8. Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs
9. Dry eye disorders
10. Intraocular penetration of topically applied cyclosporin
11. Clinical evaluation of 1% cyclosporin for topical treatment of keratoconjunctivitis sicca in dogs
12. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: Treatment with cyclosporin eye drops
13. Update on topical cyclosporin A: Background, immunology, and pharmacology
14. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields
15. Effect of cyclosporin A formulations on bovine corneal absorption: Ex vivo study
16. Cyclosporin A collyre dans la prevention du rejet de greffe de cornée à haut risque. II. Résultats cliniques
17. Ultrastructural and immunohistochemical study on the effect of topical cyclosporin A in the rabbit eye
18. Improved extemporaneous formulation of cyclosporin A ophthalmic drops
19. Pilot trial of cyclosporin 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca
20. Pharmacokinetics of topical cyclosporin A in the rabbit eye
21. Influence of emulsion droplet surface charge on indomethacin oculartissue distribution
22. Evaluation of positively-charged submicron of piroxicam on the rabbit corneum healing process following alkali burn
23. Estimation of cyclosporin A in whole blood by simple and rapid reversed-phase HPLC utilizing a salting-out extraction procedure
24. Cyclosporin ophthalmic oil/water emulsions. Formulation and characterization
25. Surface properties of mixed phospholipid-stearylamine monolayers and their interaction with a non-ionic surfactant (poloxamer)
26. The stability of piroxicam incorporated in a positively-charged submicron emulsion for ocular administration
27. Ageing effects in parentral fat emulsions: The role of fatty acids
28. The preparation and properties of sterile intravenous emulsions
29. The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsions